From advanced surgical options to next-generation medications and cell-based therapies, researchers are closer than ever to ...

Designed for advanced Parkinson’s with poorly controlled motor fluctuations, the infusion delivers steadier levodopa exposure than pills via continuous subcutaneous dosing.

In a new Cedars-Sinai study of Parkinson's disease patients, those who had taken common medications to control pain, blood pressure, diabetes or cholesterol saw their symptoms begin years later than ...

It’s improving quality of life. Parkinson’s drugs are meant to keep patients in what’s called their “on state,” providing improvement in coordination and stiffness. But as the drugs wear off between ...

Drugs commonly prescribed to treat Parkinson's disease have been linked to impulse control disorders such as pathological gambling, compulsive buying, hypersexuality and binge eating in some patients, ...

With the introduction of adaptive deep brain stimulation (aDBS) for Parkinson's disease, new questions emerge regarding who, why, and how to treat. This paper outlines the pathophysiological rationale ...

Shares of Japan's Sumitomo Pharma fell over 15% on the back of profit-taking after a specialist panel endorsed its iPS cell-based therapy for Parkinson's disease.

When someone develops a tremor or experiences slowed movements, Parkinson’s disease often comes to mind first. However, several neurological conditions present with remarkably similar symptoms, ...

Commonly prescribed medications such as statins, non-steroidal anti-inflammatory drugs and certain blood pressure drugs may significantly delay the onset of Parkinson’s disease. The study, published ...